Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
Clinical trial NCT01318317 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01318317
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-19
- Primary completion
- 2013-10-03
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.